PulmOne’s MiniBox+ is the first Complete Pulmonary Function Testing (PFT) system with desktop, cabinless, and gasless plethysmography, as well as Spirometry and DLCO testing. Clinically proven, testing is easily performed with automatic measurements, and is fully reimbursable in many health plans in the US. Results are highly reproducible, with lung volumes correlating more closely to body plethysmography than other office-based devices. The MiniBox+ has been validated in hundreds of patients in multiple medical centers. The MiniBox+ meets all American Thoracic Society (ATS) and European Respiratory Society (ERS) guidelines, and testing is reimbursable in the US. PulmOne has offices in the US, France, UK, and Brazil.
$500K sweet spot round size
2006
$500K
from investors over 1 rounds
PulmOne Advanced Medical Devices Ltd raised $500K on June 24, 2013